Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-07

FDA Approved: EPTIFIBATIDE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved EPTIFIBATIDE from Sagent Pharmaceuticals via an Original Application, marking regulatory approval for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

ORIG AP for EPTIFIBATIDE (EPTIFIBATIDE)